Skip to content
Clinical Trials – home

Centro Médico Iza

Verified siteinfo

Spain Calle Añil S/N, Local 3, 28760 Madrid, Spain

  • 1 trial recruiting
  • Asthma · Conjunctivitis allergic · Rhinitis allergic
  • Adults and children

About Specializations

Centro Médico Iza in Madrid, Spain specialises in clinical trials of conditions such as Asthma, Conjunctivitis allergic, Rhinitis allergic, Seasonal allergy, and other specialisations. This site conducts important research.

Main research areas of the site

Allergy and Immunology

The medical center is at the forefront of allergy and immunology research, focusing on innovative treatments for allergic conditions. The center's research is particularly concentrated on developing vaccines for grass and cupressaceae allergies, aiming to improve the quality of life for patients suffering from these conditions.

  • Vaccine development for grass and cupressaceae allergies
  • Subcutaneous administration of polymerized allergen extracts
  • Management of allergic rhinitis and rhinoconjunctivitis

By evaluating the clinical efficacy of these vaccines, the center contributes significantly to the advancement of therapeutic options for patients with allergic rhinitis and rhinoconjunctivitis, with or without associated asthma.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Calle Añil S/N, Local 328760 MadridSpain
Recruiting now
1 trial
Conditions studied
4
Partner status
Verified site

More sites in MadridSpain

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Effectiveness and Safety of a Grass and Juniperus Oxycedrus Allergy Vaccine for Patients with Allergic Rhinitis or Rhinoconjunctivitis with or without Mild Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.

Conjunctivitis allergic+3

Not recruiting

Study on the Effectiveness and Safety of a Grass and Olive Pollen Allergy Vaccine for Patients with Allergic Rhinitis or Asthma

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.